HR3162Referred to Committee
Affordable and Safe Prescription Drug Importation Act of 2025
Introduced
In Committee
3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2025-05-01
Introduced
5
Cosponsors
HR
ⓘType
Sponsor
Janice D. Schakowsky
Democrat · IL · Representative
Votes with party: 98.3% (521 recorded votes)
Full profile: /officials/S001145
Source: Congress.gov · FEC
Cosponsors (5)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Energy and CommerceReferred To · 2025-05-01
Previously
- Energy and Commerce CommitteeReferred To · 2025-05-01
Plain-English Summary
Affordable and Safe Prescription Drug Importation Act of 2025 This bill expands the categories of prescription drugs that may be imported into the United States and the countries from which such drugs may be imported. Current law allows the Department of Health and Human Services (HHS) to authorize importation of certain eligible prescription drugs from Canada if HHS certifies that doing so would pose no additional risk to public health and safety, among other requirements. HHS long declined to make the requisite certification, citing safety concerns (e.g., contamination, counterfeiting), but ultimately made the certification in 2020 and has since approved one state plan to import drugs. The bill removes the certification requirement and requires HHS to issue regulations that permit importation of qualifying prescription drugs from the United Kingdom, Switzerland, and member states of the European Union, in addition to Canada. After one year, if HHS determines that importation of drugs from these countries has been conducted safely, HHS may authorize importation from other countries that meet certain requirements. The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin. Further, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS. Finally, the bill imposes criminal penalties for websites that sell counterfeit drugs or dispense drugs without a required prescription.
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Health
Full bill text is not yet cached locally.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HRES1316Expressing the sense of the House of Representatives to reduce traffic fatalities to zero by 2050.Referred to Committee · 2026-05-21
- HR8907IMPACT to Save Moms ActReferred to Committee · 2026-05-19
- HR8423Energy Consumer Protection Act of 2026Referred to Committee · 2026-04-21
- HR8311Protecting American Consumers from Robocalls ActReferred to Committee · 2026-04-15